Orgenesis Inc. Faces Delisting Concerns

Ticker: ORGS · Form: 8-K · Filed: Apr 19, 2024 · CIK: 1460602

Orgenesis INC. 8-K Filing Summary
FieldDetail
CompanyOrgenesis INC. (ORGS)
Form Type8-K
Filed DateApr 19, 2024
Risk Levelhigh
Pages3
Reading Time3 min
Key Dollar Amounts$1.00, $12,397,000, $15,372,000, $5,000,000 m, $2,500,000
Sentimentbearish

Sentiment: bearish

Topics: delisting, listing-standards, compliance

Related Tickers: OGNS

TL;DR

OGNS might get delisted, check exchange rules.

AI Summary

Orgenesis Inc. filed an 8-K on April 19, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The earliest event reported was on April 17, 2024. The company is incorporated in Nevada and its principal executive offices are located in Germantown, MD.

Why It Matters

This filing indicates potential issues with Orgenesis Inc.'s compliance with stock exchange listing requirements, which could lead to its shares being delisted.

Risk Assessment

Risk Level: high — A notice of delisting or failure to meet listing standards poses a significant risk to the company's stock trading status.

Key Players & Entities

FAQ

What specific listing rule or standard has Orgenesis Inc. failed to satisfy?

The filing does not specify the exact rule or standard that Orgenesis Inc. has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.

What is the earliest date of the event reported in this 8-K?

The earliest event reported in this 8-K was on April 17, 2024.

When was this 8-K filing submitted to the SEC?

This 8-K filing was submitted to the SEC on April 19, 2024.

Where are Orgenesis Inc.'s principal executive offices located?

Orgenesis Inc.'s principal executive offices are located at 20271 Goldenrod Lane, Germantown, MD 20876.

What is Orgenesis Inc.'s state of incorporation?

Orgenesis Inc. is incorporated in Nevada.

Filing Stats: 776 words · 3 min read · ~3 pages · Grade level 14.2 · Accepted 2024-04-19 16:05:29

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. ORGENESIS INC. Date: April 19, 2024 By: /s/ Victor Miller Victor Miller Chief Financial Officer, Treasurer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing